RxDoctor Payments DataLook up a doctor →

Jeffrey Declaire, MD

Adult Reconstructive Orthopaedic Surgery · Rochester, MINPI 1265442446

Payments from drug & device makers

$5,527,550in general payments, 2019–2025

Across 452 payments — averaging $12,229 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$5.4M
  • Omnilife Science, Inc$87K
  • Encore Medical, LP$42K
  • Smith+Nephew$17K
  • Bioventus LLC$1K
  • Corin USA$1K
  • plus $675 from 10 others
$50,111in research payments, 2019–2025

Across 13 payments — averaging $3854.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$26K
  • Omnilife Science, Inc$24K

What the payments were for

  • Royalty or licence$5,253,40497%
  • Consulting fees$106,0232%
  • Travel & lodging$49,3161%
  • Food & beverage$10,1630%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,527,550 in reported general payments places this provider in the 95th percentile of 35 adult reconstructive orthopaedic surgery providers in Michigan.

See all adult reconstructive orthopaedic surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$264,975
Medicare patients
429
Services billed
1,703

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib82$1,540
Diclofenac Sodium80$1,081
Amoxicillin101$217
Methylprednisolone20$113
Gabapentin13$69
Meloxicam16$68
Clindamycin Hcl25$55

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Rochester

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →